Curtin School of Allied Health, Curtin University, Perth, Australia.
Therapy Services, Ability WA, Perth, Australia.
Phys Occup Ther Pediatr. 2024;44(4):586-603. doi: 10.1080/01942638.2023.2263576. Epub 2023 Oct 10.
Determine the feasibility of a gamified therapy (occupational therapy, physiotherapy, speech pathology) prescription app developed for children with neurodisability for delivering school and home therapy programs (the Zingo app).
A mixed-methods feasibility study was conducted with children (and their parents, therapists, and teachers) with neurodisability ( = 8, female= 5) who were prescribed a 4-week individualized therapy program by their usual treating therapist using Zingo. Primary outcome measures were program adherence, engagement, app quality, and user experience, collected with quantitative and qualitative methods.
Mean adherence to the program was 58.0% (SD 27.2). Our combined Engagement Index (EI) score was 74.4% (SD 11.7). App quality measured using Mobile Application Rating Scale- User version was 4.6/5 (SD 0.7, = 6) for parents, 4.6/5 (SD 0.5, = 5) for teachers, and 4.4/5 (SD 0.6, = 6) for therapists. Thematic analysis of semi-structured interviews yielded a primary theme of "app as motivator" for therapy.
Adherence findings were affected by COVID-19 outbreak however remain comparable with other studies in this cohort. EI findings compared favorably with other studies. The findings are supportive of the feasibility of Zingo for delivering home and school therapy programs for children with neurodisability and was found to motivate therapy program completion.
确定为神经发育障碍儿童开发的游戏化治疗(职业治疗、物理治疗、言语病理学)处方应用程序(Zingo 应用程序)在提供学校和家庭治疗方案方面的可行性。
对 8 名(其中 5 名为女性)神经发育障碍儿童(及其父母、治疗师和教师)进行了一项混合方法可行性研究,他们的常规治疗师使用 Zingo 为其开了为期 4 周的个体化治疗方案。主要结果测量包括使用定量和定性方法收集的方案依从性、参与度、应用程序质量和用户体验。
方案的平均依从率为 58.0%(SD 27.2)。我们的综合参与指数(EI)评分为 74.4%(SD 11.7)。使用移动应用程序评级量表-用户版本对应用程序质量进行测量,父母评分为 4.6/5(SD 0.7,=6),教师评分为 4.6/5(SD 0.5,=5),治疗师评分为 4.4/5(SD 0.6,=6)。半结构化访谈的主题分析得出了一个主要主题,即“应用程序作为治疗的动力”。
尽管 COVID-19 爆发对依从性的研究结果产生了影响,但仍与该队列中的其他研究相当。EI 的研究结果与其他研究相比表现良好。研究结果支持 Zingo 在为神经发育障碍儿童提供家庭和学校治疗方案方面的可行性,并发现其能激励治疗方案的完成。